Accueil>>Signaling Pathways>> Neuroscience>> Monoamine Oxidase>>PAT-1251

PAT-1251 (Synonyms: PAT-1251; GB2064)

Catalog No.GC30112

PAT-1251 est un inhibiteur oral puissant et sélectif de la lysyl oxydase-like 2 (LOXL2), avec des IC50 de 0,71 et 1,17 μM pour hLOXL2 et hLOXL3 respectivement. Il inhibe également efficacement la LOXL2 chez la souris, le rat et le chien (IC50s de 0,10, 0,12 et 0,16 μM respectivement). PAT-1251 est utilisé dans la recherche sur les maladies fibrotiques.

Products are for research use only. Not for human use. We do not sell to patients.

PAT-1251 Chemical Structure

Cas No.: 2007885-39-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
657,00 $US
En stock
5mg
597,00 $US
En stock
10mg
873,00 $US
En stock
25mg
1 792,00 $US
En stock
50mg
2 712,00 $US
En stock
100mg
4 136,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PAT-1251 is a potent, selective and oral Lysyl Oxidase-Like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively); PAT-1251 has entered clinical development with the potential to treat a number of fibrotic diseases.

PAT-1251 is a Lysyl Oxidase-Like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively). PAT-1251 shows highly selective for LOXL2 over other key members of the amine oxidase family, such as the copper-dependent amine oxidases semicarbazide-sensitive amine oxidase (SSAO) and diamine oxidase (DAO), in addition to the flavin-dependent monoamine oxidases A (MAO-A) and B (MAO-B), with <10% inhibition at 10 μM[1].

[1]. Rowbottom MW, et al. Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2). J Med Chem. 2017 May 25;60(10):4403-4423.

Avis

Review for PAT-1251

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PAT-1251

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.